Caffeine impairs short-term neurological outcome after concussive head injury in rats

Neurosurgery

Volumn 53, Issue 3, 2003, Pages 704-712

  Al Moutaery, Khalaf ^a   Al Deeb, Saleh ^a   Khan, Haseeb Ahmad ^a   Tariq, Mohammad ^a   Valadka, Alex B ^b   Narayan, Raj K ^b   Yeh, David ^b  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^b NONE

Author keywords

Adenosine; Caffeine; Free radicals; Head injury; Neurotrauma; Secondary injury

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; FREE RADICAL; MALONALDEHYDE; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CONCUSSION; BRAIN EDEMA; BRAIN FUNCTION; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG RECEPTOR BINDING; EPILEPSY; FEMALE; HEAD INJURY; HYPOXIA; LIPID PEROXIDATION; LYMPHOCYTIC INFILTRATION; MEMBRANE PERMEABILITY; MICROSCOPIC ANATOMY; MORTALITY; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; RELATIVE DENSITY; TREATMENT OUTCOME; WATER CONTENT;

EID: 0041854534     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000079487.66013.6F     Document Type: Article

References (91)

1. Ahmed S, Vaitkevicius VK, Zalupski MM, Du W, Arlauskas P, Gordon C, Kellogg C, Shields AF: Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: A phase II study. Am J Clin Oncol 23;420-424, 2000.
2. 2 levels after different ischemic periods in rat brain tissue. Prostaglandins Leukot Essent Fatty Acids 42:67-71, 1991.
3. Al-Deeb S, Al-Moutaery K, Arshaduddin M, Biary N, Tariq M: Effect of acute caffeine on severity of harmaline induced tremor in rats. Neurosci Lett 325:216-218, 2002.
4. Al Moutaery K, Al Deeb S, Biary N, Morais C, Ahmad Khan H, Tariq M: Effect of aluminum on neurological recovery in rats following spinal cord injury. J Neurosurg 93[Suppl 2]:276-282, 2000.
5. Andine P, Rudolphi KA, Fredholm BB, Hagberg H: Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 ofrat hippocampus during transient ischaemia. Br J Pharmacol 100:814-818,1990.
6. Atkinson JLD: The neglected prehospital phase of head injury: Apnea and catecholamine surge. Mayo Clin Proc 75:37-47, 2000.
7. Barone FC, Hillegass LM, Price WJ, White RF, Feuerstein GZ, Saran HM, Clark RK, Griswold DE: Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxide activity assay and histologic verification. J Neurosci Res 29:336-348, 1991.
8. Becker AB, Simons KJ, Gillespie CA, Simons FE: The bronchodilator effects and pharmacokinetics of caffeine in asthma. N Engl J Med 310:743-746, 1984.
9. Berne RN, Rubio R, Curnish RR: Release of adenosine from ischemic brain. Circ Res 35:262-271, 1974.
10. Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209, 1982.
11. Buck LT, Bickler PE: Adenosine and anoxia reduce N-methyl-D-aspartate receptor open probability in turtle cerebrocortex. J Exp Biol 201:289-297, 1998.
12. Burg AW: Effects of caffeine on the human system. Tea Coffee Trade J 147:40-42, 1975.
13. Collins WF: A review and update of experimental and clinical studies of spinal cord injury. Paraplegia 21:204-219, 1983.
14. Cronstein BN: Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13, 1994.
15. Czosnyka M, Smielewski P, Piechnik S, Steiner L, Pickard J: Cerebral auto-regulation following head injury. J Neurosurg 95:756-763, 2001.
16. Daly: Mechanism of action of caffeine, in Garattini S (ed): Caffeine, Coffee and Health. New York, Raven Press, 1993, pp 97-150.
17. Darakchiev BJ, Itkis M, Agajanova T, Itkis A, Hariri RJ: Changes of MPO activity and brain water accumulation in traumatic brain injury experiments. Acta Neurochir (Wien) 70:98-101, 1997.
18. Dempsey RJ, Baskaya MK, Dogan A: Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery 47:399-406, 2000.
19. Derlett RW, Tseng JC, Albertson TE: Potentiation of cocaine and D-amphetamine toxicity with caffeine. Am J Emerg Med 10:211-216, 1992.
20. Dolphin AC, Archer ER: An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci Lett 43:49-54, 1983.
21. Dunwiddie TV, Hoffer BJ: Adenosine nucleotides and synaptic transmission in the in vitro rat hippocampus. Br J Pharmacol 69:59-68, 1980.
22. Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA: Caffeine citrate for the treatment of apnea of prematurity: A double-blind, placebo-controlled study. Pharmacotherapy 20:644-652, 2000.
23. Eun BL, Liu XL, Barks JD: Pentoxifylline attenuates hypoxic-ischemic brain injury in immature rats. Pediatr Res 47:73-78, 2000.
24. Evans MC, Swan JH, Meldrum BS: An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus. Neurosci Lett 83:287-292, 1987.
25. Faden AI, Demediuk P, Panter SS, Vink R: The role of excitatory amino acids and NMDA receptors in traumatic head injury. Science 244:798-800, 1989.
26. Fredholm BB: Adenosine, adenosine receptors and the action of caffeine. Pharmacol Toxicol 76;93-101, 1995.
27. Fredholm BB: Adenosine and neuroprotection. Int Rev Neurobiol 40:259-280, 1997.
28. Garthwaite G, Hajos F, Garthwaite J: Ionic requirements for neurotoxic effects of excitatory amino acid analogues in rat cerebellar slices. Neuroscience 18:437-447, 1986.
29. Golding EM, Vink R: Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury. Mol Chem Neuropathol 24:137-150, 1995.
30. Griffiths RR, Vernotica EM: Is caffeine a flavoring agent in cola soft drinks? Arch Family Med 9:727-734, 2000.
31. Hall ED: High dose of glucocorticoid treatment improves neurological recovery in head-injured mice. J Neurosurg 62:882-887, 1985.
32. Hall ED, Andrus PK, Yonkers PA, Smith SL, Zhang JR, Taylor BM, Sun FF: Generation and detection of hydroxyl radical following experimental head injury. Ann N Y Acad Sci 738:15-24, 1994.
33. Hall ED, Yonkers PA, Horan KL: Correlation between attenuation of post-traumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006 F: Evidence for an in vivo antioxidant mechanism. J Neurotrauma 6:169-176, 1989.
34. Heron A, Larbennes F, Seylaz J: Adenosine modulation of amino acid release in rat hippocampus during ischemia and veratridine depolarization. Brain Res 608:27-32, 1993.
35. Hsu CY, Halushka PV, Hogan EL, Banik NL, Lee WA, Perot PL: Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury. Neurology 35:1003-1009, 1985.
36. Hudone S, Palmer C, Roberts RL, Manger D, Housman C, Towfighi J: The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 41:607-616, 1997.
37. Ikeda Y, Long DM: Comparative effects of direct and indirect hydroxyl radical scavengers on traumatic brain edema. Acta Neurochir Suppl (Wien) 51:74-76, 1990.
38. Inci S, Ozcan OE, Kilinc K: Time-level relationship for lipid peroxidation and the protective effect of a-tocopherol in experimental mild and severe brain injury. Neurosurgery 43:330-336, 1998.
39. Kamimori GH, Penetar DM, Headley DB, Thorne DR, Otterstetter R, Belenky G: Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness. Eur J Clin Pharmacol 56:537-544, 2000.
40. Karas M, Chakrabarti SK: Influence of caffeine on allyl alcohol-induced hepatotoxicity in rats: Part I - In vivo study. J Environ Pathol Toxicol Oncol 20:141-154, 2001.
41. Karhapaa L, Tornquist K: Effects of caffeine on the influx of extracellular calcium in GH4C1 pituitary cells. J Cell Physiol 171:52-60, 1997.
42. Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischaemia and stroke. Stroke 23:1367-1379, 1992.
43. Kulkarni C, Joseph T, David J: Inhibition of anticonvulsant action of carbamazepine by aminophylline and caffeine in rats. Indian J Exp Biol 27:1048-1051, 1989.
44. Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A: Caffeine as an analgesic adjuvant. J Am Med Assoc 251:1711-1718, 1984.
45. Leker RR, Shohami E: Cerebral ischemia and trauma-different etiologies yet similar mechanisms: Neuroprotective opportunities. Brain Res Brain Res Rev 39:55-73, 2002.
46. Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella ILG: The effects of low doses of caffeine on human performance and mood. Psychopharmacology 92:308-312, 1987.
47. Ligouri A, Robinson JH: Caffeine antagonism of alcohol-induced driving impairment. Drug Alcohol Depend 63:123-129, 2001.
48. Maggirwar SB, Dhanraj DN, Somani SM, Ramkumar V: Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201:508-515, 1994.
49. Marmarou A, Poll W, Shulman K: A simple gravimetric technique for measurement of cerebral edema. J Neurosurg 49:530-537, 1978.
50. McIntosh TK, Vink R, Soares H, Hayes R, Simon R: Effects of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J Neurochem 55:1170-1179, 1990.
51. Molnar D, Torok K, Erhardt E, Jages S: Safety and efficacy of treatment with an ephedrine/caffeine mixture: The first in adolescents. Int J Obes Relat Metab Disord 24:1573-1578, 2000.
52. Morii S, Winn HR, Berne RM: Effect of theophylline, an adenosine receptor blocker on cerebral blood flow (CBF) during rest and transient hypoxia. J Cereb Blood Flow Metab 3[Suppl 1]:S480-S481, 1983.
53. Nakamichi T: Glutamate neurotoxicity during spinal cord ischemia: The neuroprotective effects of adenosine [in Japanese]. Jpn J Thorac Cardiovasc Surg 46:354-360, 1998.
54. Nehlig A, Daval JL, Debry G: Caffeine and the central nervous system: Mechanism of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 17:139-170, 1992.
55. Nilsson B, Ponten U: Experimental head injury in the rat: Part 2 - Regional brain energy metabolism in concussive trauma. J Neurosurg 47:252-261, 1977.
56. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358, 1979.
57. Okiyama K, Smith DH, Gennarelli TA, Simon RP, Leach M, McIntosh TK: The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J Neurochem 64:802-809, 1995.
58. Osterholm JL, Mathews GJ: Altered norepinephrine metabolism following experimental spinal cord injury: Part I - Relationship to hemorrhagic necrosis and post-wounding neurological deficits. J Neurosurg 36:386-394, 1972.
59. Petkov VV, Rousseva S: Effects of caffeine on aggressive behavior and avoidance learning of rats with isolation syndrome. Methods Find Exp Clin Pharmacol 6:433-436, 1984.
60. Puiroud S, Pinard E, Seylaz J: Dynamic cerebral and systemic circulatory effects of adenosine, theophylline and dipyridamole. Brain Res 453:287-298, 1988.
61. Rudolphi KA, Keil M, Grome JJ: Adenosine: A pharmacological concept for the treatment of cerebral ischemia? in Krieglstein J, Oberpichler H (eds): Pharmacology of Cerebral Ischemia. Stuttgart, Wissenschaftliche Verlagsgesellschraft mbH, 1990, pp 439-448.
62. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB: Neuroprotective role of adenosine in cerebral ischemia. Trends Pharmacol Sci 13:439-445, 1992.
63. Ruijter J, Lorist MM, Snel J, De Ruiter MB: The influence of caffeine on sustained attention: An ERP study. Pharmacol Biochem Behav 66:29-37, 2000.
64. Salzman SK, Hirofuji E, Llados-Eckman C, MacEwen GD, Beckman AL: Monoaminergic responses to spinal trauma: Participation of serotonin in posttraumatic progression of neural damage. J Neurosurg 66:431-439, 1987.
65. Sandler AN, Tator CH: Review of the effect of spinal cord trauma on the vessels and blood flow in the spinal cord. J Neurosurg 45:638-646, 1976.
66. Sawynok J, Yaksh TL: Caffeine as an analgesic adjuvant: A review of pharmacology and mechanisms of action. Pharmacol Rev 45:43-85, 1993.
67. Schubert P, Mitzdorf U: Analysis and quantitative evaluation of the depressive effect of adenosine on evoked potentials in hippocampal slices. Brain Res 172:186-190, 1979.
68. 2+ influxes. Brain Res 376:382-386, 1986.
69. Schubert P, Ogata T, Marchini C, Ferroni S, Rudolphi K: Protective mechanisms of adenosine in neurons and glial cells. Ann N Y Acad Sci 825:1-10, 1997.
70. Shapira Y, Artru AA, Cotev S, Muggia-Sulam M, Freund HR: Brain edema and neurologic status following head trauma in the rat. Anesthesiology 77:79-85, 1992.
71. Shapira Y, Artru AA, Yadid G, Shohami E: Methylprednisolone does not decrease eicosanoid concentrations or edema in brain tissue or improve neurologic outcome after head trauma in rats. Anesth Analg 75:238-244, 1992.
72. Shapira Y, Setton D, Artru AA, Shohami E: Blood-brain barrier permeability, cerebral edema, and neurologic function after closed head injury in rats. Anesth Analg 7:141-148, 1993.
73. Shapira Y, Shohami E, Sidi A, Soffer D, Freeman S, Cotev S: Experimental closed head injury in rats: Mechanical, pathophysiologic, and neurologic properties. Crit Care Med 16:258-265, 1988.
74. Shapira Y, Yadid G, Cotev S, Niska A, Shohami E: Protective effect of MK-801 in experimental brain injury. J Neurotrauma 3:131-139, 1990.
75. Shapiro P: Caffeine for allergic rhinitis. Lancet 1:793, 1982.
76. Smith SL, Andrus PK, Zhang JR, Hall ED: Direct measurement of hydroxyl radicals, lipid peroxidation and blood-brain barrier disruption following unilateral cortical impact head injury in the rat. J Neurotrauma 11:393-404, 1994.
77. Soustiel JF, Shik V, Feinsod M: Basilar vasospasm following spontaneous and traumatic subarachnoid haemorrhage: Clinical implications. Acta Neurochir (Wien) 144:137-144, 2002.
78. Sullivan GW, Luong LS, Carper HT, Barnes RC, Mandell GL; Methylxanthines with adenosine alter TNF α-primed PMN activation. Immunopharmacology 31:19-29, 1995.
79. Sutherland GR, Peeling J, Lesiuk HJ, Brownstone RM, Rydzy M, Saunders JK, Geiger JD: The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology. Neuroscience 42;171-182, 1991.
80. Taoka Y, Okajima K, Uchiba M, Murakami K, Harada N, Johno M, Naruo M, Okabe H, Takatsuki K: Reduction of spinal cord injury by administration of iloprost, a stable prostacyclin analog. J Neurosurg 86:1007-1011, 1997.
81. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, Naruo M, Okabe H, Takatsuki K: Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats. Crit Care Med 25:874-879, 1997.
82. Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15-26, 1991.
83. Turcani P, Tureani M: Effect of propentofylline on cerebral blood flow in a gerbil focal cerebral ischemia. J Neurol Sci 183:57-60, 2001.
84. Ustun ME, Gurbilek M, Ak A, Vatansev H, Duman A: Effects of magnesium sulfate on tissue lactate and malondialdehyde levels in experimental head trauma. Intensive Care Med 27:264-268, 2001.
85. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sujita M: Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 8:282-284, 1988.
86. Watanabe H, Ikeda M, Watanabe K: Properties of rotational behavior produced by methylxanthine derivatives in mice with unilateral 6-hydroxydopamine-induced lesions. J Pharmacobiodyn 4:301-307, 1981.
87. Wei EP, Kontos HA: Role of adenosine in cerebral arteriolar dilation from arterial hypoxia. J Cereb Blood Flow Metab 1[Suppl 1]:S395-S396, 1981.
88. Wilson JT, Gross CE, Bednar MM, Schackford SR: U83836E reduces secondary brain injury in a rabbit model of cryogenic trauma. J Trauma 39:473-477, 1995.
89. Winn HR, Rubio R, Beme RM: Brain adenosine production during 60 seconds of ischemia. Circ Res 45:486-492, 1979.
90. Winn HR, Welsh JE, Rubio R, Bem M: Brain adenosine production in rat during sustained alteration in systemic blood pressure. Am J Physiol 239: H639-H641, 1980.
91. Zubkov AY, Pilkington AS, Parent AD, Zhang J: Morphological presentation of posttraumatic vasospasm. Acta Neurochir Suppl (Wien) 76:223-226, 2000.